Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2025-07-18–present
Board Member
Amphastar Pharmaceuticals, Inc. (AMPH)Equibles does not estimate personal net worth.
Get an email with a short summary when Amphastar Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AMPH alertsDavid Gaugh is recorded as Board Member at Amphastar Pharmaceuticals, Inc. (AMPH) since July 18, 2025. Amphastar Pharmaceuticals, Inc. reported in an 8-K filed July 21, 2025 that David Gaugh was appointed Class I director, effective July 18, 2025. Amphastar Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amphastar Pharmaceuticals, Inc. includes Jack Yongfeng Zhang (CEO and Board Member), William J. Peters (CFO and Board Member), William Peters (CFO) and 7 others.
“On July 18, 2025, the Board of Directors (the "Board") of Amphastar Pharmaceuticals, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the "Nominating Committee"), approved an increase to the authorized number of directors permitted to serve on the Board from ten (10) to eleven (11) directors and appointed David Gaugh, to serve as a Class I director, to hold office until the Company's 2026 annual meeting of stockholders and until his successor is duly elected and qualified or until his earlier death, resignation or removal, effective immediately.”
2025-07-18–present
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2025-07-18–present